Effect of High-Dose Oral Rabeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic Ulcers

Table 1

Demographics (ITT population).

	Oral rabeprazole group (𝑛=54)	IV omeprazole group (𝑛=52)	𝑃 value
Age (yr)	56.1±16.2	57.1±15.8	0.729
Age group			0.496
<70 yr	43	38
≥70 yr	11	14
Sex (M/F)			0.227
Male	46	39
Female	8	13
Symptoms at presentation			0.356
Hematemesis	11	7
Melena	27	27
Hematochezia	1	1
Hematemesis + melena	12	12
Hematemesis + hematochezia	2	0
Other	1	5
Alcohol use	30	31	0.698
Smoking	25	24	1.000
NSAID use	5	1	0.206
Pulse (beats/min)	86.7±13.8	90.7±16.7	0.183
Blood pressure (mm Hg)
Systolic	109.4±19.2	116.0±23.2	0.111
Diastolic	67.6±13.1	68.8±14.3	0.662
Hemoglobin (g/dL)	9.9±2.5	9.6±2.7	0.569
Hematocrit (%)	29.4±7.3	28.5±7.8	0.549
Comorbid illness	34	36	0.543

ITT: intention-to-treat; IV: intravenous; NSAID: nonsteroidal anti-inflammatory drug.